Positron emission tomographic analysis of central dopamine D1 receptor binding in normal subjects treated with the atypical neuroleptic, SDZ MAR 327.

International journal of molecular medicine

Volumn 1, Issue 1, 1998, Pages 243-247

  Christian, B T ^a   Babich, J W ^a   Livni, E ^a   Alpert, N M ^a   Bonab, A A ^a   Munconi, L ^a   Polinski, R ^a   Rubin, R H ^a   Fischman, A J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ERGOLINE DERIVATIVE; NEUROLEPTIC AGENT; SDZ MAR 327;

ADULT; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; MALE; METABOLISM; METHODOLOGY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADULT; ANTIPSYCHOTIC AGENTS; DOPAMINE ANTAGONISTS; ERGOLINES; HUMANS; MALE; RECEPTORS, DOPAMINE D1; TOMOGRAPHY, EMISSION-COMPUTED;

MLCS; MLOWN;

EID: 0031598638     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.1.1.243     Document Type: Article

References (0)